Drawing for KINPLEX

USPTO serial 87607907

KINPLEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
I, DAVID C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KINPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary S. Consalvi

Mary S. Consalvi PROSKAUER ROSE LLPELEVEN TIMES SQUARENEW YORK, NY 10036-8299UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and reagents for use in biochips, not for medical or veterinary purposes; chemical test kits for identifying infectious agents, nucleic acids, biological characteristics, or chemical profiles for laboratory or research useACTIVE—
005Diagnostic test kits consisting primarily of biological components, namely, enzymes, nucleic acids and proteins, and chemical components, namely, buffers and reagents, for use in disease testing, identifying infectious agents, nucleic acids, proteins and other biological materials, biological characteristics or chemical profilesACTIVE—
009Biochips for research or scientific purposes; laboratory equipment, namely, workstations for test and evaluation of nucleic acids, proteins and other biological materials, comprising biochips, software, detectors, reagents, nucleic acid purification, amplification and separation and detection components, and computer security software; portable detection and identification instruments using biochips for detecting and identifying biological substances not for medical purposes; scientific instrument, namely, biochip and instrument system for crime scene investigations of DNA; computer software and hardware for analysis of biochip data and results; software for ensuring the security of electronic mail and dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 15, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 15, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2020EX4GSOU EXTENSION 4 GRANTED—
Aug 4, 2020EXT4SOU EXTENSION 4 FILED—
Aug 4, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 16, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 14, 2020EX3GSOU EXTENSION 3 GRANTED—
Jan 14, 2020EXT3SOU EXTENSION 3 FILED—
Jan 14, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 15, 2019EX2GSOU EXTENSION 2 GRANTED—
Jul 15, 2019EXT2SOU EXTENSION 2 FILED—
Jul 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2019EX1GSOU EXTENSION 1 GRANTED—
Jan 29, 2019EXT1SOU EXTENSION 1 FILED—
Jan 29, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 7, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 12, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 12, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 3, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 3, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Nov 3, 2017CNSLSUSPENSION LETTER WRITTEN—
Nov 3, 2017DOCKASSIGNED TO EXAMINER—
Sep 19, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 18, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance